Monday, May 16, 2022

Latest:

Social burnout post-pandemic
Alone at the hands of healthcare: hospital visitor policies during the COVID-19 pandemic
Overactive brain circuit causes anorexia in animal model
Save or splurge: nutrition
Abdominal Wall Hernias and How Telemedicine is Streamlining the Path to Hernia Repair

Baylor College of Medicine Blog Network

Blog Network
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

Acute Lymphoblastic Leukemia

From The Labs

Applying basic science helps predict poor treatment outcomes in ALL

November 21, 2019November 21, 2019Acute Lymphoblastic Leukemia, ALL, carbon metabolism, metabolome, Pediatric Cancer, prognosis, Research

The survival of patients with pediatric acute lymphoblastic leukemia (ALL) has significantly improved in the last several decades, but there is still a group of

From The Labs

Exploring the risk of ALL in children with Down syndrome

September 24, 2019September 24, 2019Acute Lymphoblastic Leukemia, ALL, CDKN2A gene, Childhood leukemia, Down syndrome, IKZF1 gene, Research

Acute Lymphoblastic Leukemia (ALL) is the most common childhood cancer. Children with trisomy 21 (Down syndrome) are 10 to 20 times more likely to develop ALL

From the Labs: A closer look at tertiary lymphoid structures. Image courtesy of M. Zelazowski/ P. Castro/Baylor’s Human Tissue Acquisition & Pathology (HTAP) Core.